Retrieve available abstracts of 98 articles: HTML format
Single Articles
July 2025
SASAKI K, Fujita K, Fujihara S, Iwama H, et al The Polyphenol (-)-Epigallocatechin-3-gallate (EGCG) Inhibits the Proliferation
of Gastric Cancer Cells and Alters microRNA Signatures.
Anticancer Res. 2025;45:2925-2936. PubMedAbstract available
June 2025
BASKAR S, Schoeneich R, Grewal US In-hospital Outcomes Between Total Parenteral Nutrition and Enteral Feeding in
Esophageal and Gastric Cancer: A Nationwide Analysis.
Anticancer Res. 2025;45:2453-2457. PubMedAbstract available
May 2025
KANG M, Kim KJ, Sung JH, Nam M, et al Development of Acquired Resistance in Alpelisib-treated Gastric Cancer Cells With
PIK3CA Mutations and Overcoming Strategies.
Anticancer Res. 2025;45:1877-1896. PubMedAbstract available
HOJO Y, Tomita T, Igeta M, Murakami M, et al Impact of Nivolumab Plus Chemotherapy on Conversion Therapy in Clinical Stage IVB
HER2-negative Gastric Cancer.
Anticancer Res. 2025;45:2091-2102. PubMedAbstract available
ZHOU N, Yuan Y, Lin H, Wang J, et al Epigallocatechin Gallate Induces miR-192/215 Suppression of EGR1 in Gastric
Cancer.
Anticancer Res. 2025;45:1935-1951. PubMedAbstract available
LAI LW, Yamashita T, Otsuka K, Saito A, et al Rare Upper Mediastinal Oligometastasis from Early Esophagogastric Adenocarcinoma:
A Case Report.
Anticancer Res. 2025;45:2109-2114. PubMedAbstract available
JANG BI, Jung JY, Koh SA, Park YE, et al MAP17 as a Mediator of HGF-induced Proliferation and Invasion in Gastric Cancer.
Anticancer Res. 2025;45:2011-2024. PubMedAbstract available
April 2025
LIM SC, Lee TB, Han SI Caffeic Acid Phenethyl Ester Inhibits Metastatic Properties of Acid-adapted
Gastric Cancer Cells.
Anticancer Res. 2025;45:1525-1534. PubMedAbstract available
FURUSAWA K, Furuta M, Onishi M, Hama T, et al Nivolumab Plus 5-Fluorouracil/Leucovorin+Oxaliplatin for Gastric Cancer With
Severe Peritoneal Metastasis.
Anticancer Res. 2025;45:1583-1592. PubMedAbstract available
TAKAHASHI T, Matsunaga T, Saito H, Osaki T, et al Comparison of Postoperative Outcomes of Laparoscopic Versus Open Gastrectomy in
Older Patients With Gastric Cancer.
Anticancer Res. 2025;45:1667-1679. PubMedAbstract available
FUTAWATARI N, Fukuyama T, Akimoto Y, Maehara J, et al Association Between Kita-kyushu Lung Cancer Antigen-1 Expression in Gastric
Cancer and Helicobacter pylori-infection Status.
Anticancer Res. 2025;45:1599-1606. PubMedAbstract available
IZUTSU R, Osaki M, Seong H, Sato R, et al Hepatic Stellate Cells Activated by Cancer Cell-derived AMIGO2-containing Small
Extracellular Vesicles Promote Cancer Cell Migration by Producing IL-8.
Anticancer Res. 2025;45:1435-1446. PubMedAbstract available
KURODA K, Toyokawa T, Tsujio G, Miki Y, et al Significance of Systemic Inflammatory Markers as Prognostic Predictors in Stage
II/III Gastric Cancer Among Older Patients.
Anticancer Res. 2025;45:1681-1694. PubMedAbstract available
March 2025
IMAI T, Futamura M, Mori R, Yasufuku I, et al Expression of the Niemann-Pick C1-like 1 Protein in Gastric Cancer.
Anticancer Res. 2025;45:965-975. PubMedAbstract available
ESASHI R, Aoyama T, Yamamoto S, Maezawa Y, et al The CONUT Score Can Predict the Prognosis of Gastric Cancer Patients After
Curative Treatment.
Anticancer Res. 2025;45:1251-1260. PubMedAbstract available
KAWADA J, Sakai D, Kimura Y, Hirao M, et al A Phase II Trial of Trastuzumab Combined With Irinotecan in Patients With
Advanced HER2-positive Chemotherapy-refractory Gastric Cancer (OGSG1203
HERBIS-5): Final Results.
Anticancer Res. 2025;45:1077-1085. PubMedAbstract available
KOMORI K, Yamada T, Ando S, Nagasawa S, et al Clinical Significance of Residual Lymph Node Metastasis in Predicting Recurrence
After Preoperative Chemotherapy and Surgery for Gastric Cancer.
Anticancer Res. 2025;45:1205-1214. PubMedAbstract available
February 2025
HUANG CJ, Shieh PC, Yang JS, Li YC, et al Pterostilbene Suppressed Cell Viability, Induced Apoptosis and Autophagy of
Cisplatin-resistant Gastric Cancer Cells.
Anticancer Res. 2025;45:511-523. PubMedAbstract available
KOMORI K, Abiko F, Ichikawa T, Ando K, et al Impact of Perioperative Rehabilitation on Postoperative Length of Hospital Stay
for Patients With Gastric Cancer.
Anticancer Res. 2025;45:817-822. PubMedAbstract available
January 2025
SUGIMOTO N, Kawada J, Oka Y, Ueda S, et al Salvage-line of Capecitabine Plus Oxaliplatin Therapy (XELOX) for Patients With
Inoperable/Advanced Gastric Cancer Resistant/Intolerant to Cisplatin (OGSG1403).
Anticancer Res. 2025;45:307-313. PubMedAbstract available
TSURUDA Y, Masuda T, Hiraki Y, Kitagawa M, et al Circulating Pre-microRNA-488 in Blood Is a Potential Prognostic Biomarker in
Gastric Cancer.
Anticancer Res. 2025;45:123-133. PubMedAbstract available
December 2024
ZHOU F, Zhuo J, Xu X, Pan D, et al Circular RNA hsa_circ_0004650 Enhances 5-Fluorouracil Resistance in Gastric
Cancer via Sponging miR-145-5p.
Anticancer Res. 2024;45:173-187. PubMedAbstract available
AOYAMA T, Hashimoto I, Maezawa Y, Esashi R, et al Perioperative Anemia Is an Independent Prognostic Factor for Gastric Cancer
Patients Who Receive Curative Treatment.
Anticancer Res. 2024;44:5551-5557. PubMedAbstract available
November 2024
FUJIMOTO D, Kobayashi H PAR1 Is a Candidate Target for the Treatment of Peritoneal Dissemination in
Gastric Cancer.
Anticancer Res. 2024;44:4857-4867. PubMedAbstract available
OSHIMA T, Yoshikawa T, Miyagi Y, Morita S, et al Biomarker Study for Selecting Neoadjuvant Chemotherapy Regimens Based on
Prognostic Prediction Using Gastric Cancer Biopsy Specimens from a Phase II
Randomized Controlled Trial.
Anticancer Res. 2024;44:4951-4960. PubMedAbstract available
FU CK, Lee HT, Chen JC, Yang MD, et al Contributions of Tissue Inhibitor of Metalloproteinase-1 Genotypes to the Risk of
Metastasis in Gastric Cancer.
Anticancer Res. 2024;44:4833-4841. PubMedAbstract available
HIGASHI T, Kimura M, Kato Y, Hattori K, et al Impact of Pre-operative Lymphocyte and Albumin Combination on Adjuvant
Chemotherapy and Prognosis of Gastric Cancer.
Anticancer Res. 2024;44:5051-5058. PubMedAbstract available
FUJIYA K, Serizawa M, Ohshima K, Umehara R, et al A Gene Expression Signature that Predicts Gastric Cancer Sensitivity to PARP
Inhibitor Therapy.
Anticancer Res. 2024;44:4779-4788. PubMedAbstract available
October 2024
FU CK, Chien WC, Chen YJ, Yang MD, et al Impacts of Matrix Metalloproteinase-8 Genotypes, Smoking, Alcohol Drinking, and
Helicobacter Pylori Infection on Gastric Cancer.
Anticancer Res. 2024;44:4225-4232. PubMedAbstract available
OSHIMA T, Hashimoto I, Hiroshima Y, Kimura Y, et al Clinical Significance of Granzyme B Gene Expression in Pathological Stage II/III
Gastric Cancer After Curative Gastrectomy.
Anticancer Res. 2024;44:4537-4542. PubMedAbstract available
BYEON SJ, Chang MS, Park HE, Kang D, et al Predictive Biomarkers of Lymph Node Metastasis in Early Gastric Cancer: A
Reference of Clinicopathological Characteristics, Protein Expression,
Epstein-Barr Virus Status, and Microsatellite Instability.
Anticancer Res. 2024;44:4435-4448. PubMedAbstract available
OSHIMA T, Hashimoto I, Hiroshima Y, Kimura Y, et al Clinical Significance of HRNR Expression in Patients With Stage II/III Gastric
Cancer After Curative Gastrectomy.
Anticancer Res. 2024;44:4579-4584. PubMedAbstract available
September 2024
AOYAMA T, Maezawa Y, Hashimoto I Open, Laparoscopy-assisted, Robotic-assisted Distal Gastrectomy for Gastric
Cancer: Evidence from Randomized Clinical Trials.
Anticancer Res. 2024;44:3737-3745. PubMedAbstract available
ARIGAMI T, Matsushita D, Shimonosono M, Hirase Y, et al Clinical Significance of Body Weight Loss During Chemotherapy for Advanced
Gastric Cancer Undergoing Conversion Surgery.
Anticancer Res. 2024;44:4031-4037. PubMedAbstract available
HASHIMOTO I, Nakayama Y, Tanabe M, Morita J, et al Inflammatory Burden Index Prognostic Impact in Patients With Gastric Cancer After
Gastrectomy: A Propensity Score-matched Analysis.
Anticancer Res. 2024;44:3995-4001. PubMedAbstract available
August 2024
HASHIMOTO I, Komori K, Onuma S, Watanabe H, et al Preoperative Visceral-to-Subcutaneous Fat Ratio by Sex as a Predictor of
Postoperative Survival in Patients With Gastric Cancer.
Anticancer Res. 2024;44:3515-3524. PubMedAbstract available
July 2024
SATO Y, Yamashita H, Yagi K, Nomura S, et al Ramucirumab Beyond Disease Progression After Paclitaxel Plus Ramucirumab in
Gastric Cancer: A Phase II Trial.
Anticancer Res. 2024;44:3125-3131. PubMedAbstract available
June 2024
TAKAHASHI N, Fujisaki M, Takano Y, Takeshita K, et al New Proposal Strategy of Sentinel Lymph Node Navigation Surgery for Endoscopic
Curability C-2: A Retrospective Study.
Anticancer Res. 2024;44:2717-2724. PubMedAbstract available
LI Y, Tazawa H, Nagai Y, Fujita S, et al Senescent Fibroblasts Potentiate Peritoneal Metastasis of Diffuse-type Gastric
Cancer Cells via IL-8-mediated Crosstalk.
Anticancer Res. 2024;44:2497-2509. PubMedAbstract available
PARK JW, Kim W, Kang HG, Kim WJ, et al DNA Hypermethylation Inhibits the CD82 Metastasis Suppressor Gene in Gastric
Cancer.
Anticancer Res. 2024;44:2459-2470. PubMedAbstract available
KOMORI K, Yamada T, Ando S, Hashimoto I, et al Comparison of Survival Between ypStage and pStage in Gastric Cancer.
Anticancer Res. 2024;44:2661-2670. PubMedAbstract available
May 2024
SUN SL, Sarofim M, Morris DL Transhepatic Bromelain and Acetylcysteine for Treatment of Posterior Gastric
Pseudomyxoma Peritonei: A Case Report.
Anticancer Res. 2024;44:2239-2241. PubMedAbstract available
SHIROSAKI T, Kawai N, Ebihara Y, Murai A, et al Aldehyde Dehydrogenese-1 High Cancer Stem-like Cells/Cancer-initiating Cells
Escape from Cytotoxic T Lymphocytes due to Lower Expression of Human Leukocyte
Antigen Class 1.
Anticancer Res. 2024;44:1877-1883. PubMedAbstract available
AOYAMA T, Hashimoto I, Maezawa Y, Hara K, et al The Clinical Impact of the Prognostic Immune and Nutritional Index in Gastric
Cancer Patients Who Received Curative Treatment.
Anticancer Res. 2024;44:2231-2238. PubMedAbstract available
JUNG JY, Koh SA, Lee KH Cold-shock Domain Protein A (CSDA) Influences Hepatocyte Growth Factor-medicated
Cell Proliferation and Metastasis in Gastric Cancer Cells.
Anticancer Res. 2024;44:1973-1981. PubMedAbstract available
KUM SJ, Jung YY, Kim HS Comparison of Clinicopathological and Prognostic Characteristics Between Minimal
Deviation Adenocarcinoma and Gastric-type Endocervical Adenocarcinoma.
Anticancer Res. 2024;44:2193-2204. PubMedAbstract available
April 2024
AOYAMA T, Hashimoto I, Maezawa Y, Hara K, et al Clinical Impact of the Lymphocyte-to-Monocyte Ratio in Patients With Gastric
Cancer who Received Curative Treatment.
Anticancer Res. 2024;44:1567-1574. PubMedAbstract available
HWANG SH, Kim DJ Nomogram for Predicting Infectious Complications Following Curative Gastrectomy
Using Clinical and Laboratory Parameters.
Anticancer Res. 2024;44:1781-1790. PubMedAbstract available
NUMAKURA S, Uozaki H Gastric Cancer With the Increased Nicotinamide N-methyltransferase-positive
Stromal Cells Includes Unfavorable Prognosis-related Cancer-associated
Fibroblasts.
Anticancer Res. 2024;44:1653-1660. PubMedAbstract available
MORINO K, Yamamoto M, Shimoike N, Iwasaki Y, et al Safety and Limitations of Laparoscopic Total Gastrectomy for Gastric Cancer: A
Comparative Analysis of Short and Long-term Outcomes With Open Surgery.
Anticancer Res. 2024;44:1759-1766. PubMedAbstract available
AOYAMA T, Maezawa Y, Hashimoto I, Hara K, et al The CRP-albumin-lymphocyte (CALLY) Index Is an Independent Prognostic Factor for
Gastric Cancer Patients who Receive Curative Treatment.
Anticancer Res. 2024;44:1629-1636. PubMedAbstract available
AGATSUMA Y, Nakanishi K, Tanaka C, Kanda M, et al Risk Factors for Long-term Body Weight Loss After Proximal Gastrectomy: A
Retrospective Analysis.
Anticancer Res. 2024;44:1645-1651. PubMedAbstract available
CHEN G, Shang J, Feng X, Li M, et al Hsa_circTCF25 Facilitates Oncogenesis in Gastric Cancer Cells by Modulating
miR-149 Expression.
Anticancer Res. 2024;44:1475-1485. PubMedAbstract available
February 2024
OSHIMA T, Hashimoto I, Hiroshima Y, Kimura Y, et al Clinical Significance of Tryptophanyl-tRNA Synthetase 1 Gene Expression in
Patients With Locally Advanced Gastric Cancer.
Anticancer Res. 2024;44:673-678. PubMedAbstract available
KONDO J, Yoshino S, Iida M, Takeda S, et al Effects of Extended Fixation on Advanced Gastric Cancer HER2 Status Assessment
Using IHC and FISH.
Anticancer Res. 2024;44:621-630. PubMedAbstract available
TANABE M, Aoyama T, Nakazono M, Morita J, et al Comparison of Dietary Intake After Gastric Cancer Gastrectomy Between Patients
With and Without Postoperative Surgical Complications.
Anticancer Res. 2024;44:839-844. PubMedAbstract available
MATSUMOTO T, Toya R, Shimohigashi Y, Yamaguchi K, et al Influence of Respiratory Motion on Dose Distribution in Gastric Mucosa-associated
Lymphoid Tissue Lymphoma Radiotherapy.
Anticancer Res. 2024;44:687-694. PubMedAbstract available
TAKAHASHI N, Takano Y, Takeshita K, Toya N, et al Proctoring System Enables Safe Induction of Robotic Gastrectomy: Short-term
Outcomes of the First 10 Cases.
Anticancer Res. 2024;44:823-828. PubMedAbstract available
January 2024
ITO S, Kuramochi H, Serizawa A, Ota M, et al Long-term Results of a Phase II Study of Neoadjuvant SOX for Advanced Gastric
Cancer.
Anticancer Res. 2024;44:195-204. PubMedAbstract available
OSHIMA T, Hashimoto I, Hiroshima Y, Kimura Y, et al Asialoglycoprotein Receptor 2 Expression in Patients With Locally Advanced
Gastric Cancer After Curative Resection.
Anticancer Res. 2024;44:397-402. PubMedAbstract available
SHIMONOSONO M, Arigami T, Matsushita D, Tsuruda Y, et al Evaluation of Quality of Life and Prognosis of Gastric Cancer Patients After
Laparoscopic Subtotal Gastrectomy.
Anticancer Res. 2024;44:387-396. PubMedAbstract available
OSHIMA T, Hashimoto I, Hiroshima Y, Kimura Y, et al Clinical Significance of Pregnancy Zone Protein Expression in Patients With
Locally Advanced Gastric Cancer After Curative Resection.
Anticancer Res. 2024;44:369-374. PubMedAbstract available
OSHIMA T, Hashimoto I, Hiroshima Y, Kimura Y, et al Clinical Significance of Chitinase-3-like Protein 1 Gene Expression in Patients
With Locally Advanced Gastric Cancer.
Anticancer Res. 2024;44:307-312. PubMedAbstract available
MORITA J, Aoyama T, Nakazono M, Tanabe M, et al Dietary Intake After Surgery in Patients With Gastric Cancer Who Underwent
Laparoscopic-assisted Versus Those Who Underwent Conventional Gastrectomy.
Anticancer Res. 2024;44:409-415. PubMedAbstract available
December 2023
AOYAMA T, Maezawa Y, Hashimoto I, Hara K, et al The Clinical Influence of Geriatric Nutritional Risk Index in Patients With
Gastric Cancer Who Receive Curative Treatment.
Anticancer Res. 2023;43:5605-5612. PubMedAbstract available
SATO S, Kunisaki C, Tamura Y, Yago A, et al Ramucirumab Plus Paclitaxel as a Second-line Chemotherapy in Older Adults With
Advanced Gastric Cancer (YCOG1601).
Anticancer Res. 2023;43:5663-5670. PubMedAbstract available
MUKOYAMA T, Kanaji S, Sawada R, Harada H, et al Safety and Efficacy of Neoadjuvant Chemotherapy for Advanced Gastric Cancer in
Elderly Patients.
Anticancer Res. 2023;43:5649-5656. PubMedAbstract available
November 2023
OTSUKA R, Hayashi H, Uesato M, Hayano K, et al Inflammatory and Nutritional Indices as Prognostic Markers in Elderly Patients
With Gastric Cancer.
Anticancer Res. 2023;43:5261-5267. PubMedAbstract available
AOYAMA T, Hashimoto I, Maezawa Y, Hara K, et al The C-reactive Protein to Prealbumin Ratio Is an Independent Prognostic Factor
for Patients With Gastric Cancer Who Receive Curative Surgery.
Anticancer Res. 2023;43:5181-5187. PubMedAbstract available
HORI N, Tazawa H, Li Y, Okura T, et al Intraperitoneal Administration of p53-armed Oncolytic Adenovirus Inhibits
Peritoneal Metastasis of Diffuse-type Gastric Cancer Cells.
Anticancer Res. 2023;43:4809-4821. PubMedAbstract available
SANO A, Sohda M, Hosoi N, Tateno K, et al Importance of Progression-free Survival in Second-line Chemotherapy in Patients
With Advanced or Recurrent Gastric Cancer.
Anticancer Res. 2023;43:5205-5213. PubMedAbstract available
YAMAMOTO M, Omori T, Shinno N, Hara H, et al Adjuvant Chemotherapy With S-1 Plus Docetaxel Versus S-1 Plus Oxaliplatin in
Stage III Gastric Cancer.
Anticancer Res. 2023;43:5015-5024. PubMedAbstract available
MATSUNAGA T, Satio H, Sakano YU, Makinoya M, et al Skeletal Muscle Mass Before Second-line Chemotherapy Correlates With Subsequent
Prognosis and Rate of Late-line Chemotherapy in Patients With Unresectable
Gastric Cancer.
Anticancer Res. 2023;43:5051-5059. PubMedAbstract available
KITAGAWA H, Hiraki M, Namba T, Baba K, et al The Oncological Effect of Mutant p53 on the Metastatic Phenotype of Gastric
Cancer Cells.
Anticancer Res. 2023;43:4887-4895. PubMedAbstract available
October 2023
TSUJIO G, Yashiro M, Sakuma T, Aoyama R, et al Impact of SMAD2 and MET Expression on Lymph Node Metastasis of HER2-positive
Gastric Cancer Cells.
Anticancer Res. 2023;43:4359-4364. PubMedAbstract available
ZHANG YQ, Shi SS, Li YF, Yang Y, et al Melatonin Inhibits Gastric Cancer Cell Proliferation by Suppressing Exosome
miR-27b-3p Expression.
Anticancer Res. 2023;43:4413-4424. PubMedAbstract available
DU L, Xie F, Han H, Zhang L, et al Targeting SALL4 by Entinostat Inhibits the Malignant Phenotype of Gastric Cancer
Cells by Reducing EMT Signaling.
Anticancer Res. 2023;43:4389-4401. PubMedAbstract available
September 2023
IWASAKI H, Haraguchi E, Ihashi T, Yokomizo H, et al Risk Factor of Sarcopenia After Gastrectomy in Elderly Patients With Gastric
Cancer.
Anticancer Res. 2023;43:4207-4212. PubMedAbstract available
August 2023
SHIMIZU S, Matsunaga T, Sawata S, Sakano YU, et al Preoperative Osteopenia Is a Risk Factor for Death in Patients Undergoing
Gastrectomy for Gastric Cancer.
Anticancer Res. 2023;43:3665-3672. PubMedAbstract available
ENDO S, Yamada T, Kawada J, Higashida M, et al Proximal Resection Line Determination Using Intraoperative Radiography in
Laparoscopic Distal Gastrectomy for Gastric Cancer.
Anticancer Res. 2023;43:3685-3691. PubMedAbstract available
TANAKA Y, Aoyagi K, Umetani Y, Tanaka YU, et al Impact of Skeletal Muscle Mass Reduction on Long-term Survival After Radical
Resection of Gastric Cancer.
Anticancer Res. 2023;43:3779-3786. PubMedAbstract available
July 2023
ARIGAMI T, Matsushita D, Shimonosono M, Tsuruda Y, et al Clinical Significance of Recurrence Risk Score for Conversion Surgery in Patients
With Advanced Gastric Cancer.
Anticancer Res. 2023;43:3305-3310. PubMedAbstract available
KANAJI S, Urakawa N, Mukoyama T, Harada H, et al Safety of Laparoscopic Gastrectomy for Advanced Gastric Cancer With Greater than
Serosal Invasion Depth.
Anticancer Res. 2023;43:3145-3152. PubMedAbstract available
DAVAKIS S, Kapelouzou A, Sakellariou S, Kyriakoulis KG, et al Clinical and Oncological Impact of the Toll-like Receptor-3 and -4 in Esophageal
and Gastro-esophageal Junction Adenocarcinoma.
Anticancer Res. 2023;43:3183-3191. PubMedAbstract available
WOLL E, Amann A, Eisterer W, Gerger A, et al Treatment Algorithm for Patients With Gastric Adenocarcinoma: Austrian Consensus
on Systemic Therapy - An Update.
Anticancer Res. 2023;43:2889-2897. PubMedAbstract available
June 2023
KOMORI K, Kano K, Ando S, Watanabe H, et al Clinicopathological Characteristics and Prognosis of Mucinous Gastric Cancer.
Anticancer Res. 2023;43:2865-2871. PubMedAbstract available
SIHOMBING AM, Murata S, Shimoji M, Miyake T, et al CD44-positive Cancer Stem-like Cells as a Potential Source of Peritoneal
Metastasis After Surgery.
Anticancer Res. 2023;43:2491-2500. PubMedAbstract available
KASAHARA K, Kunisaki C, Sato S, Kondo H, et al Long-term Outcomes of Neoadjuvant Chemotherapy With Docetaxel, Cisplatin and S-1
for Stage III Gastric Cancer.
Anticancer Res. 2023;43:2841-2850. PubMedAbstract available
ITO E, Ogino I, Sugiura M, Watanabe S, et al Long-term Outcomes of Early-stage Non-stomach Gastrointestinal Mucosa-associated
Lymphoid Tissue Lymphoma Treated With Radiation Therapy.
Anticancer Res. 2023;43:2851-2857. PubMedAbstract available
HAYASHI K, Furuta M, Furusawa K, Hamaguchi T, et al Evaluation of Irinotecan and Trifluridine/Tipiracil as Fourth-line Treatments
After Third-line Nivolumab for Advanced Gastric Cancer.
Anticancer Res. 2023;43:2831-2840. PubMedAbstract available
May 2023
MIYAMOTO H, Yoshii M, Tanaka H, Nishi S, et al Dorsal Subcutaneous Fat Thickness as a Risk Factor for Pancreatic Fistula After
Gastric Cancer Surgery.
Anticancer Res. 2023;43:2171-2178. PubMedAbstract available
ITO S, Ohgaki K, Kawazoe T, Sato S, et al Survival Benefits of Laparoscopic Gastrectomy in Elderly Patients With Gastric
Cancer: Focusing on Preoperative Nutritional and Inflammatory Status.
Anticancer Res. 2023;43:2055-2067. PubMedAbstract available
YUKAWA N, Yamada T, Aoyama T, Woo T, et al Tumor DNA in Peritoneal Lavage as a Novel Biomarker for Predicting Peritoneal
Recurrence in Patients With Gastric Cancer.
Anticancer Res. 2023;43:2069-2076. PubMedAbstract available
MORINO K, Yamamoto M, Yamanaka R, Iwasaki Y, et al Clinical Impact of Laparoscopic Surgery on the Long-term Survival of Advanced
Gastric Cancer Patients With Regard to Facilitating Doublet Adjuvant
Chemotherapy.
Anticancer Res. 2023;43:2203-2209. PubMedAbstract available
April 2023
YANG YM, Ruge F, Ji KE, Jia S, et al ALCAM, Activated Leukocyte Cell Adhesion Molecule, in Clinical Gastric Cancer and
Patient's Response to Chemotherapies.
Anticancer Res. 2023;43:1463-1475. PubMedAbstract available
OTSUKA R, Morishita H, Iida K, Hayano K, et al Serum Versus Tissue SIRT1 as Potentially Valuable Biomarkers in Gastric Cancer.
Anticancer Res. 2023;43:1485-1491. PubMedAbstract available
HASHIMOTO I, Kano K, Onuma S, Suematsu H, et al Clinical Significance of Neutrophil-to-Lymphocyte Ratio/Serum Albumin Ratio in
Patients With Metastatic Gastric or Gastroesophageal Junction Cancer Administered
Trifluridine/Tipiracil.
Anticancer Res. 2023;43:1689-1697. PubMedAbstract available
AYUB A, Naeem B, Perez A, Tyler D, et al Gastric Linitis Plastica: Clinical Characteristics and Outcomes from the National
Cancer Database.
Anticancer Res. 2023;43:1543-1548. PubMedAbstract available